Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians

Microbes and Infection

Volumn 2, Issue 2, 2000, Pages 121-126

  Sebbelov, Anne M ^a   Davidson, Michael ^b   Krüger Kjær, Susanne ^c   Jensen, Henning ^d   Gregoire, Lucie ^e   Hawkins, Ileanna ^f   Parkinson, Alan J ^g   Norrild, Bodil ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d Rigshospitalet   (Denmark)

^e WAYNE STATE UNIVERSITY   (United States)

^f ALASKA NATIVE MEDICAL CENTER   (United States)

^g NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Cervical cancer; Circumpolar natives; HPV

Indexed keywords

ARTICLE; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DENMARK; ESKIMO; ETHNIC DIFFERENCE; FEMALE; GENOTYPE; GREENLAND; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS ISOLATION; WART VIRUS;

CANCER VIRUS; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPOVAVIRIDAE;

EID: 0034018184     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00276-8     Document Type: Article

References (48)

1. Parkin D.M., Muir C.S., Whelan S.L., Gao Y.T., Ferlay J., Powell J. Cancer incidence in five continents. International Agency for Research on Cancer. Vol. VI:1992.
2. Brinton L.A. Epidemiology of cervical cancer - overview. 1992;3-23 IARC Scientific Publications, Lyon.
3. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., Moreno M.H.S.V., Kurman R., Shah K.V. Prevalence of Human Papillomavirus in cervical cancer: a Worldwide perspective. J. Natl. Cancer Inst. 87:1995;796-802.
4. Franco E.L. Cancer causes revisited: Human papillomavirus and cervical neoplasia. J.N.C.I. 87:1995;779-780.
5. de Villiers E.M. Hybridization methods other than PCR: An update. Munoz N, et al. 1992;111-119 IARC Scientific Publications, Lyon.
6. Darling J.R., Sherman K.J. Relationship between human papillomavirus infection and tumours of anogenital sites other than the cervix. Munoz N, et al. 1992;223-241 IARC Scientific Publications, Lyon.
7. de Villiers E.-M. Human pathogenic papillomavirus types: An update. Curr. Top. Microbiol. Immunol. 186:1994;1-12.
8. Lorincz A.T., Reid R., Jenson B., Greenberg M.D., Lancaster W., Kurman R.J. Human Papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79:1992;328-337.
9. Howley P.M. Role of the Human Papillomaviruses in human cancer. Cancer Res. 51:1991;5019s-5022s.
10. Woodworth C.D., Bowden P.E., Doniger J., Pirisi L., Barnes W., Lancaster W.D., Dipaolo J.A. Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus type 16 and 18 DNA. Cancer Res. 48:1988;4620-4628.
11. Pecoraro G., Morgan D., Defendi V. Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells. Proc. Natl. Acad. Sci. USA. 86:1989;563-567.
12. Hummel M., Hudson J.B., Laimins L.A. Differentiation-Induced and constitutive transcription of Human Papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66:1992;6070-6080.
13. Gilles C., Piette J., Rombouts S., Laurent C., Foidart J.-M. Immortalization of human cervical keratinocytes by human papillomavirus type 33. Int. J. Cancer. 53:1993;872-879.
14. Munoz N., Bosch F.X., DeSanjosé S., Tafur L., Izarzugaza I., Gili M., Viladieu P., Navarro C., Martos C., Ascunce N., Gonzalez L.C., Caldor J.M., Guerrero E., Lörincz A., Santamaria M., Alonso de, Ruiz P., Aristizabal N., Shah K. The causal link between human Papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain. Int. J. Cancer. 52:1992;743-749.
15. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B., Scott D.R., Sherman M.E., Kurman R.J., Wacholder S., Stanton C.K., Manos M.M. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:1993;958-964.
16. Kjær S.K., van den Brule A.J.C., Bock J.E., Poll P.A., Engholm G., Sherman M.E., Walboomers J.M.M., Meijer C.J.L.M. Human papillomavirus - The most significant risk determinant of cervical intraepithelial neoplasia. Int. J. Cancer. 65:1996;601-606.
17. Human Papillomaviruses, World Health Organization. International Agency for Research in Cancer, Lyon. 1995.
18. Lanier A., Kelly J., Smith B., in. Cancer in the Alaska Native Population: Eskimo, Aleut and Indian. Incidence and trends, 1969-1988. 1993;Alaska Area Native Health Service, Anchorage Alaska.
19. Davidson M., Bulkow L.R., Lanier A.P., Smith R.A., Hawkins I., Jensen H., Kiviat N.B. Incidence of invasive cervical cancer preceded by negative screening in high-risk Alaska Native women. Int. J. Epidemiol. 23:1994;238-245.
20. Kissmeyer-Nielsen F., Andersen H., Hauge M., Kjerbye K.E., Mogensen B., Svejgaard A. HLA types in Danish Eskimos from Greenland. Tiss. Antigens. 1:1971;74-80.
21. Prener A., Højgaard Nielsen N., Storm H.H., Hart Hansen J.P., Møller Jensen O. Cancer in Greenland 1953-1985. APMIS. 99:1991;1-79.
22. Kjaer S.K., Nielsen N.H. Cancer of the female genital tract in circumpolar Inuit. Acta Oncol. 35:1996;581-587.
23. Nielsen N.H., Jensen H. Screening for cancer of the uterine cervix in Greenland. APMIS. 101:1993;290-294.
24. Møller Jensen O., Estève J., Møller H., Renard H. Cancer in the European Community and its member states. Eur. J. Cancer. 26:1990;1167-1256.
25. Storm H.H., Manders T., Friis S., Bang S. Cancer Incidence in Denmark 1988. 1991;Danish Cancer Society.
26. Sebbelov A.M., Svendsen C., Jensen H., Kjær S.K., Norrild B. Prevalence of HPV in premalignant and malignant cervical lesions in Greenland and Denmark: PCR and in situ hybridization analysis on archival material. Res. Virol. 145:1994;83-92.
27. Saiki R., Scharf S., Faloona F., Mullis K.B., Horn G.T., Erlich H.A., Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 230:1985;1350-1354.
28. Young L.S., Bevan I.S., Johnson M.A., Blomfield P.I., Bromidge T., Maitland N.J., Woodman C.B.J. The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. Brit. Med. J. 298:1989;14-18.
29. Gregoire L., Arella M., Campione-Piccardo J., Lancaster W.D. Amplification of Human Papillomavirus DNA sequences by using conserved primers. J. Clin. Microbiol. 27:1989;2660-2665.
30. Snijders P.J.F., van den Brule A.J.C., Schrijnemakers H.F.J., Snow G., Meijer C.J.L.M., Walboomers J.M.M. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J. Gen. Virol. 71:1990;173-181.
31. Saiki R.K., Bugawan T.L., Horn G.T., Mullis K.B., Erlich H.A. Analysis of enzymatically amplified Beta-globin and HLA-DQalpha DNA with allele-specific oligonucleotide probes. Nature. 324:1986;163-166.
32. Cole S.T., Danos O. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of E6 and E7 gene products. J. Mol. Biol. 193:1987;599-608.
33. Goldsborough M.D., DiSilvestre D., Temple G.F., Lorincz A.T. Nucleotide sequence of human papillomavirus type 31: A cervical neoplasia-associated virus. Virology. 171:1989;306-311.
34. Cole S.T., Streeck R.E. Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J. Virol. 58:1986;991-995.
35. Eluf-Neto J., Booth M., Munoz N., Bosch F.X., Meijer C.J.L.M., Walboomers J.M.M. Human papillomavirus and invasive cervical cancer in Brazil. Br. J. Cancer. 69:1994;114-119.
36. Ley C., Bauer H.M., Reingold A., Schiffman M.H., Chambers J.C., Tashiro C.J., Manos M.M. Determinants of genital human papillomavirus infection in young women. J. Natl. Cancer Inst. 83:1991;997-1003.
37. Riou G., Favre M., Jeannel D., Bourhis J., LeDoussal V., Orth G. Association between poor prognosis in early stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet. 335:1990;1171-1174.
38. van den Brule A.J.C., Claas E.C.J., du, Maine M., Melchers W.J.G., Helmerhorst T., Quint W.G.V., Lindeman J., Meijer S.J.L.M., Walboomers J.M.M. Use of anticontamination primers in the polymerase chain reaction for the detection of human papillomavirus genotypes in cervical scrapes and biopsies. J. Med. Virol. 29:1989;20-27.
39. Hørding U., Teglbjærg C.S., Visfeldt J., Bock J.E. Human Papillomavirus Types 16 and 18 in Adenocarcinoma of the Uterine Cervix. Gynecol. Oncol. 46:1992;313-316.
40. Bjersing L., Rogo K., Evander M., Gerdes U., Stendahl U., Wadell G. HPV 18 and Cervical Adenocarcinimas. Anticancer Res. 11:1991;123-128.
41. Higgins G.D., Phillips G.E., Smith L.A., Uzelin D.M., Burrell C.J. High prevalence of human papillomavirus transcripts in all grades of cervical intraepithelial glandular neoplasia. Cancer. 70:1992;136-146.
42. Barnes W., Delgardo G., Kurman R.J., Petrelli E.S., Smith D.M., Ahmed S., Lorincz A.T., Temple G.F., Jenson A.B., Lancaster W.D. Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol. Oncol. 29:1988;267-273.
43. Kristensen G.B., Sebbelov A.M., Norrild B., Hølund B. HPV types 11, 16 and 18 in squamous cell neoplasia of the lower genital tract. J. Vir. Dis. 1:1993;15-20.
44. De Roda Husman A.-M., Walboomers J.M.M., Meijer C.J.L.M., Risse E.K.J., Schipper M.E.I., Helmerhorst T.M., Bleker O.P., Delius H., van den Brule A.J.C., Snijders P.J.F. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int. J. Cancer. 56:1994;802-806.
45. Bauer H.M., Ting Y., Greer C.E., Chambers J.C., Tashiro C.J., Chimera J., Reingold A., Manos M. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 265:1991;472-477.
46. Becker T.M., Wheeler C.M., McCough N.S., Jordan S.W., Dorin M., Miller J. Cervical papillomavirus Infection and cervical Dysplasia in Hispanic, Native American, and Non-Hispanic White Women in New Mexico. Am. J. Public Health. 81:1991;582-586.
47. Moscicki A.-B., Palefsky J., Gonzales J., Schoolnik G.K. Human papillomavirus in sexually active adolescent females: prevalence and risk factors. Pediatr. Res. 28:1990;507-513.
48. Davidson M., Schnitzer P., Bulkow L.R., Parkinson A.J., Sshloss M.L., Fitzgerald M.A., Knight J.A., Murphy C.M., Kiviat N.B., Toomey K.E., Reeves W.C., Schmid D.S., Stamm W.E. The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska Native women. J. I. D. 129:1994;792-800.